A time scaling approach to develop an in vitro-in vivo correlation (IVIVC) model using a convolution-based technique

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 38, Issue 5, 2011, Pages 519-539

  Costello, Cian ^a   Rossenu, Stefaan ^c   Vermeulen, An ^b   Cleton, Adriaan ^d   Dunne, Adrian ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^c ABLYNX NV   (Belgium)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Convolution; Deconvolution; In vivo in vitro correlation; Time scaling

Indexed keywords

ARTICLE; CONTROLLED STUDY; CONVOLUTION BASED TECHNIQUE; DRUG FORMULATION; IN VITRO IN VIVO CORRELATION MODEL; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MATHEMATICAL MODEL; PLASMA CONCENTRATION-TIME CURVE; PREDICTION; PRIORITY JOURNAL; SLOW DRUG RELEASE; STATISTICAL ANALYSIS; TECHNIQUE; VALIDATION STUDY;

COMPUTER SIMULATION; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; HUMANS; MODELS, THEORETICAL; PHARMACEUTICAL PREPARATIONS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SOFTWARE; SOLUBILITY; TIME FACTORS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 80053200656     PISSN: 1567567X     EISSN: 15738744     Source Type: Journal    
DOI: 10.1007/s10928-011-9206-4     Document Type: Article

References (25)

1. Food and drug administration (1997) Guidance for industry: Extended release oral dosage forms: development, evaluation and application of in vitro-in vivo correlations
2. European agency for the evaluation of medicinal products (1999) Note for guidance on quality of modified release products. A: Oral dosage forms B: Transdermal dosage forms section I (quality)
3. United States Pharmacopeia 1993 In vitro and in vivo evaluation of dosage forms Pharmacopeia Forum 19 5366 5379
4. United States Pharmacopeia. (1995) Dissolution, Chap. 711. US Pharmacopeial Convention, Rockville, pp 1791-1797
5. JM Cardot E Beyssac 1993 In vitro/in vivo correlations: scientific implications and standardisation Eur J Drug Metab Pharmacokinet 8 113 120 (Pubitemid 23177464)
6. H Humbert MD Cabiac H Bosshardt 1994 In vitro-in vivo correlation of a modified release oral form of ketotifen: in vitro dissolution rate specification J Pharm Sci 83 131 136 8169778 10.1002/jps.2600830205 1:CAS:528: DyaK2cXmt1WjtA%3D%3D (Pubitemid 24224165)
7. SS Hwang J Gorsline J Louie D Dye D Guinta L Hamel 1995 In vitro and in vivo evaluation of a once-daily controlled release pseudoephedrine product J Clin Pharmacol 35 259 267 7608314 1:STN:280:DyaK2Mzjt1CltA%3D%3D
8. DT Mauger VM Chinchilli 1997 In vitro-in vivo relationships for oral extended-release drug products J Biopharm Stat 7 565 578 9358329 10.1080/10543409708835207 1:STN:280:DyaK1c%2FitlWltA%3D%3D (Pubitemid 27502174)
9. OI Corrigan Y Devlin J Butler 2003 Influence of dissolution medium buffer composition on ketoprofen release from ER products and in vitro-in vivo correlation Int J Pharm 254 147 154 12623190 10.1016/S0378-5173(03)00004-8 1:CAS:528:DC%2BD3sXhsFOrtb0%3D (Pubitemid 36298823)
10. S Takka A Sakr A Goldberg 2003 A development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets J Control Release 88 147 157 12586512 10.1016/S0168-3659(02)00490-X 1:CAS:528:DC%2BD3sXpvF2msw%3D%3D (Pubitemid 36173960)
11. Wing GM (1991) A primer on integral equations of the first kind: the problem of deconvolution and unfolding. Society for Industrial and Applied Mathematics, Philadelphia
12. A Dunne C Gaynor J Davis 2005 Deconvolution based approach for level A in vivo-in vitro correlation modelling: statistical considerations Clin Res Reg Aff 22 1 14 (Pubitemid 40756840)
13. WR Gillespie 1997 Convolution-based approaches for in vivo-in vitro correlation modelling Adv Exp Med Bio 423 53 65 1:CAS:528:DyaK1cXmslGk (Pubitemid 27347192)
14. A Dunne T O'Hara J Devane 1997 Level A in vivo-in vitro correlation: nonlinear models and statistical methodology J Pharm Sci 86 1245 1249 9383734 10.1021/js970155d 1:CAS:528:DyaK2sXmsFyms74%3D (Pubitemid 27486095)
15. A Dunne T O'Hara J Devane 1999 A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption Stat Med 18 1865 1876 10407257 10.1002/(SICI)1097-0258(19990730)18:14<1865::AID- SIM223>3.0.CO;2-P 1:STN:280:DyaK1Mzjslymsw%3D%3D (Pubitemid 29364056)
16. T O'Hara S Hayes J Davis J Devane T Smart A Dunne 2001 In vivo-in vitro correlation (IVIVC) modelling incorporating a convolution step J Pharmacokinet Pharmacodyn 28 277 298 11468941 10.1023/A:1011531226478 (Pubitemid 32643368)
17. M Pitsiu G Sathyan S Gupta D Verotta 2001 A semi-parametric deconvolution model to establish in vivo-in vitro correlation applied to OROS oxybutynin J Pharm Sci 90 702 712 11357173 10.1002/jps.1026 1:CAS:528:DC%2BD3MXksFequ78%3D (Pubitemid 32530446)
18. L Zhang S Beal L Sheiner 2003 Simultaneous vs sequential analysis for population PK/PD data I: best-case performance J Pharmacokinet Pharmacodyn 30 387 403 15000421 10.1023/B:JOPA.0000012998.04442.1f (Pubitemid 38221931)
19. Verbeke G, Molenberghs G (2000) Linear mixed models for longitudinal data. Springer, New York
20. C Gaynor A Dunne J Davis 2008 A comparison of the prediction accuracy of two IVIVC modelling techniques J Pharm Sci 97 3422 3432 17990312 10.1002/jps.21220 1:CAS:528:DC%2BD1cXpsVOrtr4%3D
21. D Brockmeier HJ Dengler D Voegele 1985 In vitro-in vivo correlation of dissolution, a time scaling problem? Transformation of in vitro results to the in vivo situation, using theophylline as a practical example Eur J Clin Pharmacol 28 291 300 4007033 10.1007/BF00543326 1:CAS:528:DyaL2MXksVams7k%3D (Pubitemid 15085155)
22. S Rossenu C Gaynor A Vermeulen A Cleton A Dunne 2008 A non linear mixed effects IVIVC model for multi-release drug delivery systems J Pharmacokinet Pharmacodyn 35 423 441 18780164 10.1007/s10928-008-9095-3 1:CAS:528: DC%2BD1cXhtFemur7E
23. G Levy 1964 Effect of dosage form on drug absorption: a frequent variable in clinical pharmacology Arch Int Pharmacodyn Ther 152 59 68 14248352 1:CAS:528:DyaF2MXnslantg%3D%3D
24. G Schliecker C Schmidt S Fuchs A Ehinger J Sandow T Kissel 2004 In vitro and in vivo correlation of buserelin release from biodegradable implants using statistical moment analysis J Control Release 94 25 37 14684269 10.1016/j.jconrel.2003.09.003 1:CAS:528:DC%2BD3sXpslCmu7Y%3D (Pubitemid 37542375)
25. Beal SL, Sheiner LB, Boeckmann A (eds) (1989-2006) NONMEM users guides. ICON Development Solutions, Ellicott